Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy
Hepatocellular carcinoma (HCC) is ranked as the second leading cancer-related death in the world. Chemotherapy is one of the most commonly used strategies for HCC patients, while the clinical application is hampered by its cytotoxicity. To address this dilemma, tumor-targeted nanotechnology has been...
Saved in:
Main Authors: | Min Guo, Ying Tang, Liang Hua, Wanling Li, Guifang Gong, Yali Zhu, Bing Zhu, Yu Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Advances in Materials Science and Engineering |
Online Access: | http://dx.doi.org/10.1155/2022/3986373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
by: Ming-Chun Ma, et al.
Published: (2014-01-01) -
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01) -
Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01) -
Biogenesis, characterization, and applications of Spirulina selenium nanoparticles
by: Asmaa S. Yassein, et al.
Published: (2025-02-01) -
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)